Insuring Health & Demographic Risk | Tokio X'press - Part 2

理研：毛髪再生につながる毛包幹細胞の培養手法を確立（動画）：　 RIKEN：Hair follicle stem cell culture method：leads to hair regeneration: RIKEN建立了毛囊干细胞培养方法，可促进头发再生

2021年02月19日By Tokio X'press Health & Safety, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Medical science

COVID-19：イベルメクチン､ランダム化二重盲検治験：イスラエルSheba（動画）：　 Randomized Double-Blinded Trial at Sheba Medical Center:Ivermectin：　舍巴医学中心的随机双盲临床试验：伊维菌素可从本质上降低COVID-19

2021年02月18日By Tokio X'press flu, Product Safety & Quality, Insuring Health & Demographic Risk, Opportunities in Nutrition & Health, Business Ethics, Pharmaceutical

COVID-19： Appili､米国でファビピラビル治験：第3相試験募集（動画）：　 Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir：　 Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新

2021年02月12日By Tokio X'press flu, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical

マッキンゼー：600億円の罰金：Purdue Pharma､Sackler family（動画）：　 McKinsey: $573 mil fine : Advising Purdue Pharma, Sackler family：　麦肯锡：对推广咨询的罚款600亿日元：就普渡制药公司，萨克勒家族提供咨询

2021年02月11日By Tokio X'press manner, contamination, 0.Pollution & Waste, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, 2.Corporate Behavior, Business Ethics, class action, 6 Society, Regulation

COVID-19：ZMPの’ライフロボットブラザーズ’：PATORO（動画）：　 COVID-19：ZMP for “Life Robot Brothers”：PATORO：　 COVID-19：“生活机器人兄弟”的ZMP：PATORO

2021年02月11日By Tokio X'press 0.Pollution & Waste, Toxic Emissions & Waste, 0.Env.Opportunities, Clean Tech, Insuring Health & Demographic Risk, Access to Health Care, ROBOT, precision

1 2 3